Company: BIAF
Filing Date: 2025-05-02
Form Type: S-1
Source: 0001641172-25-008170
Chunk: 209

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-02
Form: S-1
Chunk 209
---
3 |   |
|:-------------------------------|:----|:---------|---------:|:--|:----|:--|---------:|:--|
| Lab equipment                  |     | $        |  662,747 |   |     | $ |  647,214 |   |
| Computers and software         |     |          |   81,433 |   |     |   |   68,682 |   |
| Leasehold improvements         |     |          |   19,353 |   |     |   |    9,941 |   |
| Vehicles                       |     |          |  148,103 |   |     |   |  105,919 |   |
| Property                       
 and equipment, gross           |     |          |  911,636 |   |     |   |  831,756 |   |
| Less: accumulated depreciation 
 and amortization               |     |          | (536,251 | ) |     |   | (373,123 | ) |
| Total                          
 property and equipment, net    |     | $        |  375,385 |   |     | $ |  458,633 |   |

Total property and equipment depreciation and amortization expense was $ 162,332and $ 233,064for the years ended December 31, 2024 and 2023, respectively.

Note 6. ACCRUED EXPENSES

Accrued expenses at December 31, 2024 and 2023, are summarized below:

SCHEDULE OF ACCRUED EXPENSES

|                        |     | December 
 31,      |      2024 |     |   |      2023 |
|:-----------------------|:----|:---------|----------:|:----|:--|----------:|
| Compensation           |     | $        | 1,079,839 |     | $ |   857,037 |
| Legal and professional |     |          |    98,477 |     |   |   257,926 |
| Clinical               |     |          |   160,371 |     |   |    15,350 |
| Other                  |     |          |    60,035 |     |   |    19,498 |
| Total                  
 accrued expenses       |     | $        | 1,398,722 |     | $ | 1,149,811 |

Note